Physician profile
Anthony Bolden
NPI 1518020056
$843.20
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $315 · 2024: $399 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $140.14 | 2023-2025 | Keytruda, Lynparza |
| Medical Device Business Services, INC. | $128.60 | 2023 | Vistaseal |
| Emd Serono, INC. | $120.81 | 2024 | |
| Seagen INC. | $102.53 | 2023 | Tukysa, Padcev |
| Convatec INC. | $88.53 | 2023-2025 | |
| Daiichi Sankyo INC. | $71.01 | 2024-2025 | Enhertu |
| Pfizer INC. | $69.22 | 2024 | |
| Janssen Biotech, INC. | $54.21 | 2024 | Rybrevant, Carvykti, Talvey |
| Kite Pharma, INC. | $29.99 | 2024 | |
| Novartis Pharmaceuticals Corporation | $19.58 | 2024 | |
| Incyte Corporation | $18.58 | 2024 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bolden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.